Literature DB >> 21986386

Photodynamic therapy enhances liposomal doxorubicin distribution in tumors during isolated perfusion of rodent lungs.

C Cheng1, Y Wang, A Haouala, E Debefve, S Andrejevic Blant, T Krueger, M Gonzalez, J-P Ballini, S Peters, L Decosterd, H van den Bergh, H-B Ris, J Y Perentes.   

Abstract

BACKGROUND: Photodynamic therapy (PDT) at low drug-light conditions can enhance the transport of intravenously injected macromolecular therapeutics through the tumor vasculature. Here we determined the impact of PDT on the distribution of liposomal doxorubicin (Liporubicin™) administered by isolated lung perfusion (ILP) in sarcomas grown on rodent lungs.
METHODS: A syngeneic methylcholanthrene-induced sarcoma cell line was implanted subpleurally in the left lung of Fischer rats. Treatment schemes consisted in ILP alone (400 μg of Liporubicin), low-dose (0.0625 mg/kg Visudyne®, 10 J/cm(2) and 35 mW/cm(2)) and high-dose left lung PDT (0.125 mg/kg Visudyne, 10 J/cm(2) and 35 mW/cm(2)) followed by ILP (400 μg of Liporubicin). The uptake and distribution of Liporubicin in tumor and lung tissues were determined by high-performance liquid chromatography and fluorescence microscopy in each group.
RESULTS: Low-dose PDT significantly improved the distribution of Liporubicin in tumors compared to high-dose PDT (p < 0.05) and ILP alone (p < 0.05). However, both PDT pretreatments did not result in a higher overall drug uptake in tumors or a higher tumor-to-lung drug ratio compared to ILP alone.
CONCLUSIONS: Intraoperative low-dose Visudyne-mediated PDT enhances liposomal doxorubicin distribution administered by ILP in sarcomas grown on rodent lungs which is predicted to improve tumor control by ILP.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986386     DOI: 10.1159/000330744

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  4 in total

Review 1.  Functional Polymer Nanocarriers for Photodynamic Therapy.

Authors:  Tuanwei Li; Lifeng Yan
Journal:  Pharmaceuticals (Basel)       Date:  2018-11-30

2.  Photodynamic Priming Improves the Anti-Migratory Activity of Prostaglandin E Receptor 4 Antagonist in Cancer Cells In Vitro.

Authors:  Aaron J Sorrin; Cindy Liu; Julia Cicalo; Jocelyn Reader; Daniel Najafali; Yuji Zhang; Dana M Roque; Huang-Chiao Huang
Journal:  Cancers (Basel)       Date:  2021-10-20       Impact factor: 6.639

3.  Towards Photodynamic Image-Guided Surgery of Head and Neck Tumors: Photodynamic Priming Improves Delivery and Diagnostic Accuracy of Cetuximab-IRDye800CW.

Authors:  Chanda Bhandari; John Fakhry; Menitte Eroy; Jane Junghwa Song; Kimberley Samkoe; Tayyaba Hasan; Kenneth Hoyt; Girgis Obaid
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

4.  Low-Dose Vascular Photodynamic Therapy Decreases Tumor Interstitial Fluid Pressure, which Promotes Liposomal Doxorubicin Distribution in a Murine Sarcoma Metastasis Model.

Authors:  Jean Yannis Perentes; Yabo Wang; Xingyu Wang; Etienne Abdelnour; Michel Gonzalez; Laurent Decosterd; Georges Wagnieres; Hubert van den Bergh; Solange Peters; Hans-Beat Ris; Thorsten Krueger
Journal:  Transl Oncol       Date:  2014-05-13       Impact factor: 4.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.